This inventor holds 7 USPTO granted patents and 4 EPO patents. Top assignee: Promega Corporation. Active years: 2006-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2014
Title: Richard A. Moravec: Innovator in Biochemical Assays
Introduction
Richard A. Moravec is a prominent inventor based in Oregon, WI (US), known for his significant contributions to the field of biochemical assays. With a total of 7 patents to his name, Moravec has made strides in developing methods and kits that enhance the detection of various molecules in biological samples.
Latest Patents
Among his latest innovations are the "Kits for luminogenic and nonluminogenic multiplex assays," which provide methods and kits to detect the presence or amount of at least one molecule for an enzyme-mediated reaction in a multiplex luminogenic/nonluminogenic assay. Additionally, he has developed "Kits for detection of ATP," which include methods and kits for detecting the presence of ATP, measuring ATP concentrations, and detecting viable cells using a composition comprising an ATP-dependent enzyme and one or more ATPase inhibitors.
Career Highlights
Moravec's career is marked by his work at Promega Corporation, where he has been instrumental in advancing the company's research and development efforts. His expertise in biochemical assays has positioned him as a key figure in the field, contributing to innovative solutions that benefit various scientific applications.
Collaborations
Throughout his career, Moravec has collaborated with notable colleagues, including Terry L. Riss and Keith V. Wood. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of cutting-edge technologies.
Conclusion
Richard A. Moravec's contributions to the field of biochemical assays through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the scientific community, paving the way for advancements in molecular detection technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
